BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28292433)

  • 1. ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network.
    Wheat JC; Steidl U
    Cancer Cell; 2017 Mar; 31(3):307-308. PubMed ID: 28292433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
    Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
    Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.
    Thirant C; Ignacimouttou C; Lopez CK; Diop M; Le Mouël L; Thiollier C; Siret A; Dessen P; Aid Z; Rivière J; Rameau P; Lefebvre C; Khaled M; Leverger G; Ballerini P; Petit A; Raslova H; Carmichael CL; Kile BT; Soler E; Crispino JD; Wichmann C; Pflumio F; Schwaller J; Vainchenker W; Lobry C; Droin N; Bernard OA; Malinge S; Mercher T
    Cancer Cell; 2017 Mar; 31(3):452-465. PubMed ID: 28292442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pediatric de novo acute megakaryoblastic leukemia: an affair of complexes].
    Lopez CK; Mercher T
    Med Sci (Paris); 2018 Nov; 34(11):954-962. PubMed ID: 30526836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations.
    Lopez CK; Malinge S; Gaudry M; Bernard OA; Mercher T
    Trends Cancer; 2017 Sep; 3(9):631-642. PubMed ID: 28867167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in Leukemia and Other Cancers.
    Jetten AM
    Trends Cancer; 2019 Sep; 5(9):547-557. PubMed ID: 31474360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathways driven by ETO2-GLIS2 in aggressive pediatric leukemia.
    Thirant C; Lopez C; Malinge S; Mercher T
    Mol Cell Oncol; 2017; 4(6):e1345351. PubMed ID: 29209645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel ETO2-GLIS2 fusion and therapeutic strategy in acute megakaryoblastic leukemia].
    Thiollier C; Pflumio F; Ballerini P; Crispino JD; Bernard O; Mercher T
    Med Sci (Paris); 2012 Nov; 28(11):1013-6. PubMed ID: 23171910
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
    Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
    Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
    Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
    Aid Z; Robert E; Lopez CK; Bourgoin M; Boudia F; Le Mene M; Riviere J; Baille M; Benbarche S; Renou L; Fagnan A; Thirant C; Federici L; Touchard L; Lecluse Y; Jetten A; Geoerger B; Lapillonne H; Solary E; Gaudry M; Meshinchi S; Pflumio F; Auberger P; Lobry C; Petit A; Jacquel A; Mercher T
    Leukemia; 2023 Mar; 37(3):571-579. PubMed ID: 36585521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
    Gress V; Roussy M; Boulianne L; Bilodeau M; Cardin S; El-Hachem N; Lisi V; Khakipoor B; Rouette A; Farah A; Théret L; Aubert L; Fatima F; Audemard É; Thibault P; Bonneil É; Chagraoui J; Laramée L; Gendron P; Jouan L; Jammali S; Paré B; Simpson SM; Tran TH; Duval M; Teira P; Bittencourt H; Santiago R; Barabé F; Sauvageau G; Smith MA; Hébert J; Roux PP; Gruber TA; Lavallée VP; Wilhelm BT; Cellot S
    Blood Adv; 2024 Jan; 8(1):112-129. PubMed ID: 37729615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.
    Gruber TA; Larson Gedman A; Zhang J; Koss CS; Marada S; Ta HQ; Chen SC; Su X; Ogden SK; Dang J; Wu G; Gupta V; Andersson AK; Pounds S; Shi L; Easton J; Barbato MI; Mulder HL; Manne J; Wang J; Rusch M; Ranade S; Ganti R; Parker M; Ma J; Radtke I; Ding L; Cazzaniga G; Biondi A; Kornblau SM; Ravandi F; Kantarjian H; Nimer SD; Döhner K; Döhner H; Ley TJ; Ballerini P; Shurtleff S; Tomizawa D; Adachi S; Hayashi Y; Tawa A; Shih LY; Liang DC; Rubnitz JE; Pui CH; Mardis ER; Wilson RK; Downing JR
    Cancer Cell; 2012 Nov; 22(5):683-97. PubMed ID: 23153540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
    Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
    Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
    Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
    J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMKL chimeric transcription factors are potent inducers of leukemia.
    Dang J; Nance S; Ma J; Cheng J; Walsh MP; Vogel P; Easton J; Song G; Rusch M; Gedman AL; Koss C; Downing JR; Gruber TA
    Leukemia; 2017 Oct; 31(10):2228-2234. PubMed ID: 28174417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent detection of
    Chen Wongworawat Y; Eskandari G; Gaikwad A; Marcogliese AN; Ferguson LS; Brackett J; Punia JN; Elghetany MT; Kulkarni R; Rao PH; Ringrose J; Lopez-Terrada DH; Roy A; Curry CV; Fisher KE
    Leuk Lymphoma; 2023 Feb; 64(2):462-467. PubMed ID: 36346368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.